Skip to content
APRAPRAPR303030

Drawing based on the label description. No photo yet.

“30-mg beige tablet engraved with "APR" on one side and "30" on the other side”

APR 30 pill

Pill with imprint APR 30 is white, diamond, 12 mm and has been identified as Apremilast 30 mg. It is used for psoriatic arthritis. It is supplied by Amgen, Inc.

Apremilast 30 mg

Imprint
APR 30
Strength
30 mg
Used for
Psoriatic arthritis
Color
White
Shape
Diamond
Size
12 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Amgen, Inc
Drug class
Phosphodiesterase 4 inhibitor
NDC
55513-137, 55513-137-60, 55513-137-95, 55513-369, 55513-369-55, 55513-485, 55513-485-95, 55513-485-96, 55513-516, 55513-516-41, 55513-517, 55513-517-04, 55513-523, 55513-523-04, 55513-521, 55513-521-19, 55513-522, 55513-522-14

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Apremilast pills and guides

What is Apremilast used for?

Apremilast is used for psoriatic arthritis.

Medicine type
Phosphodiesterase 4 inhibitor
Official uses from the US prescribing label

Psoriatic Arthritis

OTEZLA is indicated for the treatment of adult patients and pediatric patients 6 years of age and older and weighing at least 20 kg with active psoriatic arthritis.

OTEZLA XR is indicated for the treatment of adult patients and pediatric patients 6 years of age and older and weighing at least 50 kg with active psoriatic arthritis.

Plaque Psoriasis

OTEZLA/OTEZLA XR is indicated for the treatment of adult patients with plaque psoriasis who are candidates for phototherapy or systemic therapy.

OTEZLA is indicated for the treatment of pediatric patients 6 years of age and older and weighing at least 20 kg with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.

OTEZLA XR is indicated for the treatment of pediatric patients 6 years of age and older and weighing at least 50 kg with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.

Oral Ulcers Associated with Behçet's Disease

OTEZLA/OTEZLA XR is indicated for the treatment of adult patients with oral ulcers associated with Behçet's Disease.

From the FDA-approved label on DailyMed (published Sep 11, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows APR and the other side shows 30.
  • It is white, diamond, 12 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Otezla.

Ingredients

Active: Apremilast

Inactive: Microcrystalline Cellulose, Croscarmellose Sodium, Magnesium Stearate, Polyvinyl Alcohol, Unspecified, Titanium Dioxide, Polyethylene Glycol, Unspecified, Talc, Ferric Oxide Red, Ferric Oxide Yellow, Ferrosoferric Oxide

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Apremilast pills